Details for Patent: 8,324,281
✉ Email this page to a colleague
Title: | Topical nepafenac formulations |
Abstract: | Topical suspension compositions of nepafenac are disclosed. The compositions are especially suitable for topical ophthalmic administration. |
Inventor(s): | Wong; Warren (Fort Worth, TX) |
Assignee: | Novartis AG (Basel, CH) |
Filing Date: | Oct 05, 2011 |
Application Number: | 13/253,648 |
Claims: | 1. A topically administrable ophthalmic composition consisting of a) 0.1% (w/v) nepafenac; b) 0.5% (w/v) carbomer; c) 0.001-0.05% (w/v) tyloxapol; d) 0.3-0.5% (w/v) sodium chloride; e) 2-3% (w/v) mannitol; f) a pH-adjusting agent in an amount sufficient to cause the composition to have a pH from 7.3-7.7; g) 0.001-0.01% (w/v) benzalkonium chloride; h) 0.001-0.1% (w/v) edetate disodium; and i) water. |